Stream link
8PM ET: https://globalmeet.webcasts.com/starthere.jsp?ei=1707802&tp_key=54848fd919
This activity is part 3 of a 3-part webinar curriculum.
Program Description
Pharmacists often provide education to patients with hyperlipidemia about the risks and health consequences associated with untreated or undertreated low-density lipoprotein cholesterol and residual cardiovascular risk. This webinar explores how the pharmacist’s involvement in the multidisciplinary care team can facilitate evidence-based incorporation of non-statin medications into hyperlipidemia treatment regimens. Examples of pharmacist-led clinical interventions to achieve treatment goals that will be discussed include medication therapy management, guideline and treatment adherence, and medication access.
Target Audience: Community pharmacists, health system pharmacists, and specialty pharmacists
Type of Activity: Application
Release date: April 1, 2025
Expiration date: June 1, 2025
Learner level: Foundational, Intermediate
Time to complete activity: 1.0 hour
Fee: Free
Educational Objectives
At the completion of this activity, participants will be able to:
- Examine current treatment protocols using non-statin therapies and which specific patient populations with cardiovascular risk would benefit from them
- Apply patient education and counseling to management plans for optimizing medication adherence and treatment initiation in hypercholesterolemia management
Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
Executive Director, Ambulatory Pharmacy Services
Grady Health System
Atlanta, Georgia
Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.0 contact hour (0.10 CEU) under the ACPE universal activity number 0290-9999-25-011-L01-P. The activity is available for CE credit through June 1, 2025.
Instructions for Completing the Activity and Receiving CPE Credit
To receive CPE credit, participants must complete the pretest, view the activity in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.
Disclosures
Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA, has the following relevant financial relationship with a commercial interest to disclose:
Grant/Research Support: Novartis
Consultant: Novartis, Regeneron
Pharmacy Times Continuing Education™ Planning Staff—Jim Palatine, RPh, MBA; Maryjo Dixon, RPh, MBA; Crissy Wilson; Susan Pordon; Brianna Winters; Chloe Taccetta, and Rebecca Green have no relevant financial relationships with commercial interests to disclose.
Anonymous peer reviewers were used as part of content validation and conflict resolution. The peer reviewers have no relevant financial relationships with commercial interests to disclose.
Educational Disclaimer
CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.
For questions about this internet CPE activity, please contact:
[email protected]
Privacy Policy and Terms of Use Information:
www.pharmacytimes.org/terms